Verrica Drug Patent Portfolio

Verrica owns 1 orange book drug protected by 4 US patents Given below is the list of Verrica's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US12290651 Devices and methods for the treatment of body surface disorders 19 Feb, 2041
Active
US11147790 Treatment of cutaneous disorders 22 Aug, 2038
Active
US12233042 Treatment of cutaneous disorders 22 Aug, 2038
Active
US11052064 Compositions, methods and systems for the treatment of cutaneous disorders 28 May, 2035
Active


Given below is the list of recent legal activities going on the following drug patents of Verrica.

Activity Date Patent Number
Patent litigations
Email Notification 10 Jun, 2025 US12290651
Recordation of Patent eCertificate of Correction 10 Jun, 2025 US12290651
Patent eCofC Notification 10 Jun, 2025 US12290651
Mail Patent eCofC Notification 10 Jun, 2025 US12290651
Notice of Final Determination -Eligible 05 Jun, 2025 US11052064
Post Issue Communication - Certificate of Correction 21 May, 2025 US12290651
FDA Final Eligibility Letter 20 May, 2025 US11052064
Information Disclosure Statement (IDS) Filed 20 May, 2025 US11052064
Recordation of Patent eGrant 06 May, 2025 US12290651
Mail Patent eGrant Notification 06 May, 2025 US12290651
Recordation of Patent Grant Mailed 06 May, 2025 US12290651
Email Notification 06 May, 2025 US12290651
Patent Issue Date Used in PTA Calculation 06 May, 2025 US12290651
Patent eGrant Notification 06 May, 2025 US12290651
Payment of Maintenance Fee, 4th Yr, Small Entity 21 Apr, 2025 US11147790


Verrica's Family Patents


Family Patents



Verrica Drug List

Given below is the complete list of Verrica's drugs and the patents protecting them.


1. Ycanth

Ycanth is protected by 4 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US12290651 Devices and methods for the treatment of body surface disorders 19 Feb, 2041
(14 years from now)
Active
US11147790 Treatment of cutaneous disorders 22 Aug, 2038
(12 years from now)
Active
US12233042 Treatment of cutaneous disorders 22 Aug, 2038
(12 years from now)
Active
US11052064 Compositions, methods and systems for the treatment of cutaneous disorders 28 May, 2035
(9 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ycanth's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List